Funding Cycle III - Letter of Intent Submission in October 1999

In this, the ROTRF’s third funding cycle, nearly half (46%) of the applications were received from North America (USA and Canada) and 44% from Europe (UK constituted the majority with 16%). The remaining 10% of the applications were submitted from Australia, New Zealand and Asia.

The Scientific Advisory Committee of the ROTRF evaluated all of the applications that were submitted electronically via the ROTRF’s homepage ( for originality and scientific excellence. The top 20 applications were invited to submit a full paper application and subsequently underwent a second thorough review by the Scientific Advisory Committee and the Board of Trustees.

ROTRF grants were finally awarded to nine applicants, five from the USA, three from Europe (Italy, The Netherlands, United Kingdom) and one from Canada. They all presented excellent and very promising research projects (see abstracts on the following pages). Their research interests focus mainly on the improvement of long-term graft survival and prevention of chronic organ dysfunction, induction of tolerance, the development of new agents and relevant immune recognition, regulation and effector mechanisms.

In this third cycle of ROTRF grant awards, 1.8 million Swiss francs were disbursed in total.